Skip to content

Advertisement

  • Erratum
  • Open Access

Erratum to: Targeting the angiotensin II type 2 receptor (AT2R) in colorectal liver metastases

  • 1Email author,
  • 1,
  • 1 and
  • 1
Cancer Cell International201010:37

https://doi.org/10.1186/1475-2867-10-37

  • Received: 18 October 2010
  • Accepted: 21 October 2010
  • Published:

The original article was published in Cancer Cell International 2010 10:19

Correction

After publication of this work [1], we noted that we inadvertently failed to properly acknowledge all of our funding agencies. The acknowledgements section has now been modified accordingly.

Notes

Declarations

Acknowledgements

This work was supported by Cancer Australia's Priority-driven Collaborative Cancer Research Scheme and is co-funded by Cancer Australia and Cure Cancer Australia Foundation. We would also like to thank the CanToo fund raisers. Dr Ager is supported by an NHMRC Post-doctoral Training Award. Ms Shu-wen Wen is supported by an Australian Rotary Health Research Fund PhD Scholarship. We would like to thank Professor Mauro Sandrin and his team from the xenotransplantation group at Austin Health (Australia), Dr Russell Hodgson and Claire Lin, for their help with CFSE and PI staining and analysis.

Authors’ Affiliations

(1)
Department of Surgery, The University of Melbourne, Austin Health, Heidelberg, Victoria, Australia

References

  1. Ager E, Chong W, Wen SW, Christophi C: Targeting the antiogensin II type 2 receptor (AT2R) in colorectal liver metastases. Cancer Cell Int. 2010, 10: 19-10.1186/1475-2867-10-19.PubMed CentralView ArticlePubMedGoogle Scholar

Copyright

Advertisement